Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Asahi Kasei Corporation

Below is an extended Asahi Kasei Corporation research listing. Click here to return to the Asahi Kasei Corporation main Biocorporate entry.

Recent Publications by Asahi Kasei Corporation:

Identification of biofoulant of membrane bioreactors in soluble microbial products.
To reveal primary biofoulant in soluble microbial products (SMP) and/or...
17th November, 2009
Microza & Water Processing Division, Asahi Kasei Chemicals Co., Ltd., Water Res. 2009 Sep;43(17):4356-62. Epub 2009 Jun 25.
DOI Direct Link
Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage.
We investigated the neuroprotective effects of fasudil's active...
3rd September, 2009
Research Center, Asahi Kasei Pharma Corporation 632-1, Mifuku, Brain Res Bull. 2009 Aug 31.
DOI Direct Link
Discovery of selective PDE4B inhibitors.
In this study the first PDE4B selective inhibitor is described....
22nd August, 2009
Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Bioorg Med Chem Lett. 2009 Jun 15;19(12):3174-6. Epub 2009 May 3.
DOI Direct Link
Collaborative work on evaluation of ovarian toxicity. 13) Two- or four-week repeated dose studies and fertility study of PPAR alpha/gamma dual agonist in female rats.
The main focus of this study was to determine the optimal dosing period in...
1st July, 2009
Laboratory for Safety Assessment & ADME, Pharmaceuticals Research Center, J Toxicol Sci. 2009;34 Suppl 1:SP137-46.
Pharmacokinetics of recombinant human soluble thrombomodulin, thrombomodulin alfa in the rat.
1. The study aimed to investigate the pharmacokinetics of thrombomodulin...
25th June, 2009
Pharmaceuticals Research Center, Asahikasei Pharma Co., Shizuoka, Japan. Xenobiotica. 2009 Feb;39(2):125-34.
DOI Direct Link
A novel enzymatic method for measuring mizoribine 5'-monophosphate levels in serum.
Inosine 5'-monophosphate dehydrogenases (IMPDH) from Oceanobacillus...
8th April, 2009
Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni-shi, Shizuoka, J Biosci Bioeng. 2008 Nov;106(5):511-4.
DOI Direct Link
A novel nucleoside kinase from Burkholderia thailandensis: a member of the phosphofructokinase B-type family of enzymes.
The genome of the mesophilic Gram-negative bacterium Burkholderia...
28th January, 2009
Asahi Kasei Pharma Corporation, Shizuoka, Japan. FEBS J. 2008 Dec;275(23):5865-72.
DOI Direct Link
Correspondence between neurological deficit, cerebral infarct size, and Rho-kinase activity in a rat cerebral thrombosis model.
Whether Rho-kinase activity is really associated with the pathogenesis of...
24th January, 2009
Laboratory for Pharmacology, Asahi Kasei Pharma, 632-1 Mifuku, J Mol Neurosci. 2009 Sep;39(1-2):59-68. Epub 2009 Jan 23.
DOI Direct Link
Recovery of high purity phosphorus from municipal wastewater secondary effluent by a high-speed adsorbent.
High purity phosphorus was recovered from municipal wastewater secondary...
24th January, 2009
Microza & Water Processing Division, Asahi Kasei Chemicals Corporation, Water Sci Technol. 2008;58(8):1601-7.
DOI Direct Link
Developmental toxicity of indium: embryotoxicity and teratogenicity in experimental animals.
Indium, a precious metal classified in group 13 (IIIB) in the periodic...
22nd January, 2009
Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, Mifuku, Congenit Anom (Kyoto). 2008 Dec;48(4):145-50.
DOI Direct Link
In vivo/in vitro study in rat embryos on indium-caused tail malformations.
Pathogenesis of indium-caused tail malformations was investigated by in...
7th January, 2009
Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, Shizuoka, Reprod Toxicol. 2008 Aug;25(4):426-32. Epub 2008 May 3.
DOI Direct Link
Enzymatic characterization of an amine oxidase from Arthrobacter sp. used to measure phosphatidylethanolamine.
Ethanolamine oxidase was screened with the aim of using it to establish a...
30th December, 2008
Asahi Kasei Pharma Corporation, Shizuoka, Japan. Biosci Biotechnol Biochem. 2008 Oct;72(10):2732-8. Epub 2008 Oct 7.
Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction.
Evidence that Rho-kinase is involved in cerebral infarction has...
17th December, 2008
Laboratory for Pharmacology, Asahi Kasei Pharma, Shizuoka, Japan. Eur J Pharmacol. 2008 Oct 10;594(1-3):77-83. Epub 2008 Jul 31.
DOI Direct Link
Lucica MI urinary myoinositol kit: a new diagnostic test for diabetes mellitus and glucose intolerance.
Diabetes mellitus is a growing healthcare problem internationally, and...
16th September, 2008
Diagnostics Department, Asahi Kasei Pharma Corporation, Tokyo, Japan. Mol Diagn Ther. 2008;12(3):189-91.

«Asahi Kasei Corporation

This page contained an extended Asahi Kasei Corporation research listing. Click here to return to the Asahi Kasei Corporation main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.